According to the latest report by IMARC Group, titled “Cholera Vaccines Market Report: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global cholera vaccines market. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global cholera vaccines market reached a value of US$ 4.36 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 8.63 Million by 2027, exhibiting a CAGR of 11.70% during 2022-2027.
Cholera refers to an intestinal disease caused by bacterial infections that spread via contaminated food and water. It leads to dehydration, diarrhea, abdominal pain, fever, loss of skin elasticity, low blood pressure, muscle cramps, dry mucous membranes, such as the inside of the mouth, throat, nose, and eyelids, etc. Cholera vaccines are effective in augmenting the production of antibodies. They can be given orally and injected intradermally or intramuscularly in the body. Cholera vaccines are prepared using the live cholera-causing bacteria to help in developing immunity against the same. Consequently, they are extensively utilized in hospitals, clinics, research and academic laboratories, etc.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/cholera-vaccines-market/requestsample
Cholera Vaccines Market Trends and Drivers:
The growing consumer awareness towards the availability of product is primarily driving the cholera vaccines market. Additionally, the launch of several favorable policies by government bodies and non-government organizations (NGOs) across the countries for conducting immunization programs is further catalyzing the market growth.
Besides this, the rising prevalence of cholera, on account of the poor sanitation and hygiene conditions in rural and geographically extended areas, is propelling the product demand. Moreover, the increasing healthcare expenditure capacities of individuals and the inflating levels of water pollution caused by sewage and factory wastes getting discharged into lakes and rivers are also acting as significant growth-inducing factors.
Apart from this, the elevating investments in R&D activities aimed at developing more efficient and cost-effective variants are anticipated to fuel the cholera vaccines market over the forecasted period.
Global Cholera Vaccines Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Astellas Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics Co. Ltd., Johnson & Johnson, Merck & Co. Inc, Pfizer Inc., PharmaChoice Canada Inc, Sanofi S.A., Takeda Pharmaceutical Company Limited and Valneva SE.
The report has segmented the market on the basis of region, vaccine type, product and end user.
Breakup by Vaccine Type:
- Whole Cell V. Cholerae O1 with Recombinant B-Subunit
- Killed Oral O1 and O139
Breakup by Product:
- Euvichol and Euvichol-Plus
Market Breakup by End User:
- Hospitals and Clinics
- Research and Academic Laboratories
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800